| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01375816 2010-020468-39 Details | 2015-06-04 Interventional | 2 | 55 | Bevacizumab Calcium Fluorouracil Irinotecan Leucovorin Levoleucovorin Colorectal Neop… Colorectal Canc… | efficacy interim analysis as per protocol - | |||
| NCT00830401 Details | 2015-06-04 Interventional | 2 | 700 | Doxycycline Congenital Abno… Minor Intra-ute… | Abnormality prevalence revealed to be much lower than expected. - | |||
| NCT00781755 Details | 2015-06-04 Interventional | 4 | 0 | Varenicline Tobacco Use Dis… | Study design was altered such that a treatment component was removed through the VA IRB. We did
not and will not begin this clinical trial. - | |||
| NCT00663455 Details | 2015-06-04 Interventional | 4 | 50 | Cyclosporine Cyclosporins Kidney Transpla… | Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to
methodological reasons. - | |||
| NCT00044837 Details | 2015-06-04 Interventional | 1 | - | Estradiol Medroxyprogeste… Medroxyprogeste… HIV Infections | - - | |||
| NCT00500240 Details | 2015-06-03 Interventional | 3 | 52 | Insulin Insulin Aspart Insulin Glargin… Insulin, Globin… Leukemia Leukemia, Lymph… Lymphoma Precursor Cell … | Terminated early due to futility. Study terminated early due to futility at the pre-determined interim analysis point. | |||
| NCT00303433 NCT00303095 Details | 2015-06-03 Interventional | 4 | - | Memantine Delirium Emergence Delir… Post-Operative … | - - | |||
| NCT00245791 Details | 2015-06-03 Interventional | 4 | - | Levofloxacin Communicable Di… Infections Urinary Tract I… Complicated Uri… | - - | |||
| NCT00202891 Details | 2015-06-03 Interventional | 4 | 0 | Sisomicin Pyoderma | No further local interest in pursuing the study. - | |||
| NCT01846026 2009-015649-21 Details | 2015-06-02 Interventional | 1/2 | 0 | Cholecalciferol Vitamin D Colitis Colitis, Ulcera… Ulcer Ulcerative Coli… | At the planned study start new treatment guidelines for this disease with new drugs were
implemented in clinical practice. - | |||
| NCT01030120 Details | 2015-06-02 Interventional | 2/3 | 0 | Etanercept Chronic Urticar… Urticaria Chronic Idiopat… | Unable to complete agreement with sponsor - | |||
| NCT01841684 2012-002434-37 Details | 2015-06-01 Interventional | 3 | 2 | Anacetrapib Homozygous Fami… Hypercholestero… Hyperlipidemias Hyperlipoprotei… Hyperlipoprotei… | - - | |||
| NCT00221494 Details | 2015-06-01 Interventional | 4 | 0 | Citalopram Pindolol Depression Depressive Diso… | PI move - | |||
| NCT01446211 2011-001219-30 Details | 2015-05-29 Interventional | 3 | 4 | Azathioprine Cyclophosphamid… Glucocorticoids Gusperimus Methotrexate Granulomatosis … Wegeners Granul… | Change of design consideration - | |||
| NCT00780455 2006-006673-24 Details | 2015-05-29 Interventional | 4 | 4 | Interferon beta… Interferon-beta Interferons Multiple Sclero… Multiple Sclero… | - Due to the very low number of patients enrolled in the study, no statistical report was done. Study was early terminated. | |||
| NCT00695318 Details | 2015-05-29 Interventional | 2 | 17 | Fluocinolone Ac… Atrophy Geographic Atro… Macular Degener… Age-Related Mac… | - - | |||
| NCT00694200 Details | 2015-05-29 Interventional | 2 | 13 | Bevacizumab Vinorelbine Breast Neoplasm… Breast Cancer | Not reached the statistical hypothesis at the interim analysis - | |||
| NCT00690118 2006-005410-13 Details | 2015-05-29 Interventional | 2 | 219 | Pioglitazone Amyotrophic Lat… Motor Neuron Di… Sclerosis | The interim analysis showed no tendency in favour of the verum group. Therefore it was decided
to stop the study prematurely. - | |||
| NCT00555217 Details | 2015-05-29 Interventional | 3 | [4 Refs] | 1448 | Lisinopril Losartan Diabetes Mellit… Kidney Diseases Kidney Disease Nephropathy Type 2 Diabetes | It was stopped primarily because of safety concerns along with low conditional power to detect
a treatment effect on the primary outcome. In October, 2012 the DMC recommended that study treatment be stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome. | ||
| NCT02218775 Details | 2015-05-28 Interventional | 1 | 0 | Aticaprant Anxiety Disorde… | Funding for the study ended with one subject consented, but not randomized - |